These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2954616)

  • 1. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
    Chen YF; Jin HK; Gist R; Oparil S
    Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF; Oparil S
    Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats.
    Linthorst AC; De Lang H; De Jong W; Versteeg DH
    Eur J Pharmacol; 1991 Aug; 201(2-3):125-33. PubMed ID: 1686754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted responsiveness of posterior hypothalamic norepinephrine to quinpirole in DOCA/NaCl hypertensive rats.
    Chen YF; Jin HK; Gist R; Oparil S
    Brain Res Bull; 1987 Apr; 18(4):563-8. PubMed ID: 2440528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats.
    Lahlou S
    Fundam Clin Pharmacol; 1999; 13(6):624-34. PubMed ID: 10626749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
    Chen YF; Nagahama S; Winternitz SR; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H71-9. PubMed ID: 4014487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY171555).
    Yang RH; Igarashi Y; Wyss JM; Chen YF
    Brain Res Bull; 1990 Jan; 24(1):97-103. PubMed ID: 2138045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats.
    Fuller RW; Hemrick-Luecke SK
    J Neural Transm; 1985; 61(3-4):161-73. PubMed ID: 3157777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.
    Igarashi Y; Chen YF; Wyss JM; Lindheimer MD; Oparil S
    Pharmacology; 1987; 35(4):194-202. PubMed ID: 2959969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.
    Kujacic M; Svensson K; Löfberg L; Carlsson A
    J Neural Transm Gen Sect; 1991; 84(3):195-209. PubMed ID: 1679336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats.
    Soltis EE; Soltis TD; Katovich MJ; Field FP
    Artery; 1986; 13(6):325-39. PubMed ID: 3778217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced depressor effect of muscimol in the DOCA/NaCl hypertensive rat: evidence for altered GABAergic activity in brain.
    Nagahama S; Dawson R; Oparil S
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):277-83. PubMed ID: 4048165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.